BASF extends offer for ProNova, Patheon closes Banner Pharmacaps deal, plus updates from Amarin, Biogen Idec/Eisai and Lonza.

Patheon has forged a deal to acquire gelatin capsule specialist Banner Pharmacaps for $255 million in a deal that boosts …
Jager-van Dijk is new Arletta Pharma Solutions CEOÂ
Tridem begins phase Ib trial of Parkinson’s disease vaccine
Trio become latest Symbiosis commercial additions
UK immunoglobulin supply faces growing pressure, report warns

